quality of life Archives - Page 2 of 3

Nutritional support management in resectable gastric cancer

Francesco Serra, Paolo Pedrazzoli, Silvia Brugnatelli, Anna Pagani, Salvatore Corallo, Giovanni Rosti, Riccardo Caccialanza, Jacopo Viganò, Ornella Carminati

Article Type

Review

Published

24 Oct 2022

This narrative review presents the most recent data on nutritional support in the resectable stages of gastric cancer, with a particular focus on perioperative strategies, and discusses malnutrition in gastric cancer, nutritional support before and after surgery, and the relationship between nutritional support and chemotherapy.

Impact of opioid-induced constipation on opioid substitution therapy management: the patient perspective

Fabio Lugoboni, Genevieve Hall, Vivek Banerji

Article Type

Original Research

Published

22 Oct 2021

This article explores the opinion of patients on the impact of constipation on the management of opioid substitution
treatment and quality of life.

A non-pharmacological approach to the treatment of urinary tract infections: case reports with Utipro® Plus

Tommaso Cai, Cristian Konstantinidis, Sam Ward

Article Type

Review

Published

24 May 2021

Using illustrative case reports, this review documents outcomes in three women with recurrent urinary tract infections who were treated with Utipro® Plus in clinical practice.

TAS-102 in metastatic colorectal cancer (mCRC): efficacy, tolerability, and quality of life in heavily pretreated elderly patients: a real-life study

Giuseppe Cicero MD PhD, Raffaele Addeo MD, Rossella De Luca PhD, Giuseppe Lo Re MD PhD, Leonardo Gulotta MD, Pierenrico Marchesa MD, Gaspare Gulotta MD PhD

Article Type

Original Research

Published

18 Sep 2020

This study evaluates the safety and efficacy of TAS-102 in heavily pretreated elderly patients with metastatic colorectal cancer.

Cutaneous adverse events and quality of life in outpatients receiving anticancer agents: results from an observational, cross-sectional study

Hae-Jin Suh Oh MD, Ángeles Flórez Menéndez PhD, Víctor Sacristán Santos MD, Francisca Fernández Ribeiro PharmD, Lucía Vilanova-Trillo DNP, Manuel Constenla Figueiras PhD, Manuel Pereiro Ferreiros PhD

Article Type

Original Research

Published

05 Aug 2020

This study evaluates the impact of cutaneous adverse events on quality of life in outpatients receiving anticancer drugs and aims to determine the differences in quality of life between conventional chemotherapy versus targeted therapies.